What Accumulus Technologies does

Accumulus Technologies, Inc. is a US-incorporated, privately held software company founded in 2021 that operates a SaaS-based cloud platform purpose-built for real-time regulatory information exchange across the global healthcare ecosystem. The company connects pharmaceutical and biotechnology sponsors with health authorities and regulators, enabling secure, simultaneous exchange of regulatory submissions, health authority Q&A, dossier collaboration, and CMC submissions across the full drug development lifecycle from discovery through post-approval. Its core product, the Accumulus Platform, is augmented by Accumulus Synergy, a module focused on modernizing interactions with and among regulators, and by Dossier Collaboration capabilities for global regulatory document management. The platform is delivered as a cloud subscription service, with one-hour onboarding and quote-based enterprise pricing, and is built on a Microsoft Azure infrastructure footprint with Okta for identity and DataDog for monitoring.

The company serves two vertical segments: pharmaceutical and biotechnology sponsors (its primary segment) and health authorities/regulatory agencies. Named enterprise customers include Amgen, Astellas, AstraZeneca, GSK, Johnson & Johnson, Eli Lilly, Merck, Roche, Sanofi, and Takeda, alongside active engagement with regulators such as SAHPRA in South Africa. The platform supports a Veeva RIM integration via an Accumulus Connector and is distributed globally through direct enterprise sales, regulator information sessions, and a multi-region industry events presence spanning DIA Global, DIA Europe, DIA Latin America, RAPS Convergence, RAPS EU, and the World Vaccine Conference. Geographic operations extend across North America (USA), Europe (UK), Africa (South Africa), and Asia (Japan).

Accumulus monetizes through enterprise SaaS subscriptions to pharmaceutical sponsors, with no publicly disclosed pricing tiers and no disclosed external funding rounds, ARR, or headcount in the available data. The leadership team comprises CEO Francisco Nogueira, Chief Product and Technology Officer Chanille Juneau, COO Jack Quigley, CCO Mervyn Hall, Chief People Officer Nahed Khairallah, and Chief Regulatory Officer Dominique Lagrave. Customer-reported outcomes cited by the company include up to 90% acceleration in global regulatory approvals, $10M+ in cost benefit, and up to 75% improvement in operational efficiency, framed against industry benchmarks of a 13-year average drug development timeline, 2 million pages per application, and $2 billion average cost to bring one new drug to market.

Name

Accumulus Technologies

Legal name

Accumulus Technologies, Inc.

Website

https://accumulustechnologies.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

Accumulus Technologies operates a SaaS cloud platform that connects pharmaceutical sponsors, health authorities, and innovators for real-time regulatory information exchange, dossier collaboration, and submission management across the global drug development lifecycle.

Ownership category

akta.pro rank

Product category

Regulatory Information Management Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Electronic Data Capture (EDC) Platforms (HLACAOAA)

akta.pro secondary industry

Industry/Vertical Cloud Platforms (e.g., Gov/Healthcare/Financial Cloud Regions) (HDABAAAL)

Keywords

• Regulatory submission software
• Pharmaceutical SaaS platform
• Healthcare data exchange
• Regulatory information management
• Drug development technology

Headquarters

HQ city

Beaverton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Platform Subscription: Cloud-based SaaS platform subscription model providing access to regulatory submission and collaboration tools. Platform is offered as a subscription service with cloud-based delivery.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Accumulus Technologies sells a SaaS-based cloud platform that connects pharmaceutical sponsors, health authorities, and innovators for real-time regulatory information exchange. The platform supports the full drug development lifecycle from discovery through post-approval, enabling collaborative dossier management, Health Authority Q&A, and submission review between sponsors and regulators worldwide.

Product overview

Accumulus Technologies offers a unified SaaS-based platform that connects the healthcare and regulatory ecosystem. The core Accumulus Platform serves as the central infrastructure for regulatory submissions, enabling information to flow securely and efficiently across the drug development lifecycle. The platform includes Accumulus Synergy as a module for modernizing regulatory interactions with health authorities, and features dossier collaboration capabilities for global regulatory document management. The system supports real-time submission, review, and collaboration from drug discovery through post-approval.

Differentiator

Problem solved

Functional benefit

Products and services

• Accumulus Platform A SaaS-based cloud solution that connects the healthcare ecosystem, enabling regulatory information to flow securely and efficiently from drug discovery to post-approval, with real-time submission, review, and collaboration capabilities for pharmaceutical sponsors, health authorities, and innovators.

Quantifiable outcome

• Accelerating global approvals by up to 90%
• +2 more outcomes

Named customers10 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Partnerships

Three partnerships are on record, tiered infrastructure.

• Microsoft AzureinfrastructureTechnology or IntegrationCloud computing platform used for processing (US) and disaster recovery (EU). Core infrastructure provider for the Accumulus platform.
• OktainfrastructureTechnology or IntegrationUser authentication service provider. Enables secure identity management for platform users.
• DataDoginfrastructureTechnology or IntegrationLogging and monitoring service used for platform performance monitoring and reliability.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Veeva Systems: Veeva's RIM suite is the dominant regulatory information management system used by Accumulus's named customers. Accumulus positions as the real-time exchange/connectivity layer that complements Veeva RIM (per the Accumulus Connector integration), making Veeva its closest functional peer in pharma regulatory workflows.
• Instem: Instem provides regulatory, safety, and submission software (e.g., SubmitSuite, Author Suite) to pharmaceutical and animal health organizations. It competes with Accumulus in regulatory submission management and information exchange, serving a comparable pharma customer base.
• ArisGlobal: ArisGlobal's LifeSphere platform offers regulatory information management, submission management, and safety/ pharmacovigilance solutions to pharma sponsors. It is a direct competitor in the regulatory workflow layer that Accumulus targets, with comparable customer base among top-tier pharma.

Broad incumbents

• IQVIA: IQVIA provides regulatory technology, clinical trial platforms, and drug development services to pharmaceutical sponsors and regulators globally. It overlaps with Accumulus in regulatory information exchange and lifecycle submission management, but as part of a much broader CRO/technology portfolio rather than a focused regulatory exchange product.
• Medidata Solutions (Dassault Systèmes): Medidata offers the Medidata Platform for clinical trials and unified data, increasingly extending into regulatory and submission workflows. It competes for the same pharma R&D technology budget as Accumulus, though from a clinical-trial-data origin rather than a regulatory-exchange origin.
• Amazon Web Services (AWS) for Health & Life Sciences: AWS provides GxP-compliant cloud infrastructure and vertical healthcare/regulatory services that compete for the same workloads Accumulus runs on Microsoft Azure. While Accumulus is an application-layer SaaS, AWS represents the broader incumbent cloud alternative for pharma regulatory workloads.
• PAREXEL (now part of EQT/GSK consortium): PAREXEL is a global CRO with regulatory affairs services and technology supporting drug submissions and health authority interactions. It is comparable to Accumulus in pharma-regulator interaction workflows, though delivered primarily through services rather than a standalone SaaS platform.
• Oracle Health Sciences (Clinical One / Regulated Industries): Oracle offers clinical trial, pharmacovigilance, and regulatory submission software as part of its Health Sciences suite. It competes with Accumulus in regulatory submission infrastructure for pharma and CROs, but as part of a much larger enterprise software portfolio spanning clinical, safety, and operational systems.

Emerging players

• Salesforce Industries (Health Cloud / Life Sciences Cloud): Salesforce Life Sciences Cloud offers CRM-anchored workflow and collaboration tools for pharma, including use cases touching regulatory, medical, and commercial teams. It overlaps with Accumulus's enterprise collaboration and information exchange value proposition at the high end of the pharma market.

Others

• Cognizant Life Sciences Regulatory Services: Cognizant provides regulatory affairs services, technology consulting, and submission management for pharma sponsors and emerging biotech. It is comparable as a buyer/competitor of regulatory technology spend and as an implementation partner that could integrate or compete with Accumulus's platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/accumulus-technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accumulus Technologies